Report - HER2/HER3 pathway in biliary tract malignancies; …...studies) and amplification rates were 27.9 % (95 % CI 9.7– 46.1 %) and 26.5 % (one study), respectively. Up to 20 % of extrahepatic

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form